Serum levels of neural protein S-100B in phenylketonuria

Clinical Biochemistry

Volumn 37, Issue 1, 2004, Pages 76-79

  Schulpis, Kleopatra H ^a   Kariyannis, Catherine ^a   Papassotiriou, Ioannis ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Phenylalanine; PKU; S 100B

Indexed keywords

BENZOPHENONE; MYELIN; PROTEIN S100B;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; NEWBORN CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0347481474     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2003.08.002     Document Type: Article

References (18)

1. Scriver C., Kaufman S., Eisensmith R., Woo S. The hyperphenylalaninemias. Scriver C., Beaudet A., Sly W., Valle D. The metabolic and molecular bases of inherited disease. 8th ed. 2000;1775-1875 McGraw-Hill, New York.
2. Burri R., Steffen C., Stieger S., Brodbeek U., Colombo J.P., Herschkowitz N. Reduced myelinogenesis and recovery in hyperphenylalaninemic rats. Correlations between brain phenylalanine levels, characteristic brain enzymes for myelination and brain development. Mol. Chem. Neuropathol. 13:1990;57-69.
3. Schulpis K.H., Scarpalezou A. Triglycerides cholesterol HDL, LDL and VDL cholesterol in serum of phenylketonuric children under dietary control. Clin. Pediatr. 28:1998;466-469.
4. Missiou-Tsagarakis S., Schulpis K., Loumakou M. Phenylketonuria in Greece, 12 years experience. J. Mental Defic. Res. 32:1988;271-287.
5. Rickmann M., Wolff J.R. S100 protein expression in a subpopulation of neurons of rat brain. Neuroscience. 67:1995;977-991.
6. Bianchi R., Vernzini M., Garbuglia M., Giambanco J., Donato K. Mechanism of S100 protein dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization. Biochim. Biophys. Acta. 1223:1994;354-360.
7. Drohn J.P., Paux E. Evaluation of an enzymatic colorimetric method for the neonatal screening of Phenylketonuric. Screening. 11:1993;410-417.
8. Gazzolo D., Vinesi P., Marinoni E., Di Iorio R., Marras M., Lituania M. et al. S100B protein concentrations in cord blood correlations with gestational age in term and preterm deliveries. Clin. Chem. 46:2000;998-1000.
9. Van Engelen B.G., Lamers K.J., Gabreels F.J., Wevers K.A., Van Geel W.J., Borm G.F. Age related changes of neuron specific enolase, S100B protein and myelin basic protein concentrations in cerebrospinal fluid. Clin. Chem. 38:1992;813-816.
10. Walz R., Portella L.V.C., Tort A.B.L., Neto E.C., Fernandez L.N., Concalves C.et al. Serum S100B levels in patients with HTLV-1 associated myelopathy tropical spastic parapleglia. Neurology. 54:2000;2021-2022.
11. Michetti F., Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin. Chem. 48:2002;2097-2104.
12. Portella L., Tort A.B., Schaf D., Ribeiro L., Nora D., Walz R.et al. The serum S100B concentration is age dependent. Clin. Chem. 48:2000;950-952.
13. Oldendorf W.H. Saturation of blood brain barrier transport of amino acids in phenylketonuria. Arch. Neurol. 28:1973;45-48.
14. Antonas K.N., Coulson W.F. Brain uptake and protein incorporation of amino acids studied in rats subjected to prolonged hyperphenylalaninemia. J. Neurochem. 25:1975;309-314.
15. Schulpis K.H., Karikas G.A., Kokotos G. Direct molecular interaction of Phenylalanine with DNA measured by a reversed phase HPLC method. Clin. Chem. 44:1998;178-179.
16. Schulpis K.H., Karikas G.A., Tjamouranis J., Tsakiris S. In vitro influence of phenylalanine on acetylcholinesterase and DNA. Z. Naturforsch. 53C:1998;291-294.
17. Tsakiris S., Kouniniotou-Krontiri P., Schulpis K.H., Stavridis J.C. L-Phenylalanine effect on rat brain acetylcholinesterase and Na+, K+ ATPase. Z. Naturforsch. 53C:1998;163-167.
18. Ziegler D.R., Innocente C.E., Leal R.B., Rodnight R., Concalces C.A. The S100B inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus. Neurochem. Res. 23:1998;1259-1260.